NDC 0409-2025

DOBUTAMINE

Dobutamine

DOBUTAMINE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Dobutamine Hydrochloride.

• Product ID: 0409-2025_43404ce8-1a3b-4019-ae84-e4b350a7401b
• NDC: 0409-2025
• Product Type: Human Prescription Drug
• Proprietary Name: DOBUTAMINE
• Generic Name: Dobutamine
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2005-11-17
• Marketing Category: ANDA / ANDA
• Application Number: ANDA074292
• Labeler Name: Hospira, Inc.
• Substance Name: DOBUTAMINE HYDROCHLORIDE
• Active Ingredient Strength: 13 mg/mL
• Pharm Classes: Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0409-2025-54

10 CARTON in 1 PACKAGE (0409-2025-54) > 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-2025-64) > 40 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2005-11-17
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0409-2025-54 [00409202554]

DOBUTAMINE INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA074292
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2005-11-17
• Marketing End Date: 2017-05-01

NDC 0409-2025-20 [00409202520]

DOBUTAMINE INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA074292
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2006-02-23

NDC 0409-2025-64 [00409202564]

DOBUTAMINE INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA074292
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-05-15

NDC 0409-2025-60 [00409202560]

DOBUTAMINE INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA074292
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2018-05-15

Drug Details

Active Ingredients

Ingredient	Strength
DOBUTAMINE HYDROCHLORIDE	12.5 mg/mL

OpenFDA Data

• SPL SET ID: cb842dc2-fb15-48f9-e4b1-ea4280db0199
• Manufacturer:
  • Hospira, Inc.
• UNII:
  • 0WR771DJXV
• RxNorm Concept Unique ID - RxCUI:
  • 1812170
  • 1812168

Pharmacological Class

• Adrenergic beta-Agonists [MoA]
• beta-Adrenergic Agonist [EPC]

NDC Crossover Matching brand name "DOBUTAMINE" or generic name "Dobutamine"

NDC	Brand Name	Generic Name
0409-2025	DOBUTAMINE	DOBUTAMINE
0409-2344	DOBUTAMINE	DOBUTAMINE
14335-171	Dobutamine	Dobutamine
14335-172	Dobutamine	Dobutamine
51662-1330	DOBUTAMINE	DOBUTAMINE
51662-1337	DOBUTAMINE	DOBUTAMINE
52584-048	Dobutamine	Dobutamine Hydrochloride Injection